1mg, best e pharmacy in India
MRP: Rs. 74.16 for 1 strip(s) (10 capsules each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition for ACMIL

Milnacipran(50 mg)

food interaction for ACMIL

alcohol interaction for ACMIL

pregnancy interaction for ACMIL

lactation interaction for ACMIL

food
alcohol
pregnancy
lactation
It can be taken with or without food, but it is better to take Acmil 50 mg capsule at a fixed time.
Acmil 50 mg capsule may cause excessive drowsiness and calmness with alcohol.
UNSAFE
Acmil 50 mg capsule may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
WEIGH RISKS VS. BENEFITS
Unknown. Human and animal studies are not available. Please consult your doctor.

SALT INFORMATION for ACMIL

Milnacipran(50 mg)

Uses

Acmil 50 mg capsule is used in the treatment of depression and diabetic nerve disease.

How it works

Acmil 50 mg capsule works in depression by increasing the levels of chemical messengers in the brain that helps in regulating mood.

Common side effects

Nausea, Rash, Gastrointestinal discomfort, Abdominal pain, Blurred vision, Constipation, Decreased sexual function, Decreased libido, Dizziness, Dry mouth, Difficulty in urination, Flatulence, Headache, Hot flashes, Indigestion, Itching, Testicular pain, Testicular swelling, Vomiting, Weight loss

SUBSTITUTES for ACMIL

3 Substitutes
Sorted By
RelevancePrice
  • MILNACE 50 MG CAPSULE
    (10 capsules in strip)
    Torrent Pharmaceuticals Ltd
    Rs. 9.80/capsule
    Capsule
    Rs. 98
    pay 32% more per capsule
  • MILBORN 50 MG CAPSULE
    (10 capsules in strip)
    Sun Pharmaceutical Industries Ltd
    Rs. 7.70/capsule
    Capsule
    Rs. 77
    pay 4% more per capsule
  • MILZA 50 MG CAPSULE
    (10 capsules in strip)
    Intas Pharmaceuticals Ltd
    Rs. 9.50/capsule
    Capsule
    Rs. 95
    pay 28% more per capsule

Top Psychiatrists

  • Dr. Kanika Mehrotra
    MBBS
    4.7
  • Dr. Anurag Mishra
    MBBS, MD
    4.6
  • Dr. Deepak Raheja
    MBBS, MD, Fellowship
    4.6
  • Dr. Puneet Dwevedi
    MBBS, MD
    4.5
  • Dr. Jyoti Kapoor Madan
    MBBS, DNB, Diploma, Fellowship
    4.1

Expert advice for ACMIL

  • Before you take Milnacipran, inform your doctor if you have a history of seizures, heart problems (eg, heart failure, irregular heartbeat), recent heart attack, high blood pressure, bleeding problems, kidney problems, liver problems, urinary blockage or trouble urinating or enlarged prostate or glaucoma (increased pressure in the eye that may lead to vision loss).
  • Do not drive or operate machinery or do any activity that requires alertness as Milnacipran may cause drowsiness, dizziness or blurred vision.
  • Do not consume alcohol or take any medicines that may cause drowsiness (e g, sleeping pills, and muscle relaxants) while on Milnacipran treatment as it may worsen its side effects.
  • Seek immediate medical attention if you feel that you are developing suicidal thoughts or actions or any unusual change in mood or behavior.
  • Take precautions as Milnacipran may put you at increased risk of severe, life threatening bleeding.
  • You may be monitored with lab tests, including blood pressure, heart rate, and liver function, while on Milnacipran treatment.
  • Tell your doctor immediately if you are pregnant, think you might be pregnant or if you are breast-feeding.
  • Milnacipran should not be used in children < 18 years old.

Frequently asked questions for ACMIL

Milnacipran

Q.Is Milnacipran addictive?
Milnacipran does not cause addiction

Q.Is Milnacipran narcotic?
Milnacipran is not a narcotic

Q.Is Milnacipran a generic or a controlled substance?
Milnacipran is a generic and not a controlled substance

Q.Does Milnacipran cause weight loss?
Milnacipran may cause this side effect. Call your doctor if you experience any unusual problems during your treatment.

Articles


Content on this page was last updated on 28 September, 2016, by Dr. Varun Gupta (MD Pharmacology)